Mo1835 Dose Escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program

Basheer Alshiwanna; Jack McNamara; William E. Wilson; Joseph L. Pipicella; Simon Ghaly; Richard Gearry; Jakob Begun; Astrid-Jane Williams; Kate D. Lynch; Ian C. Lawrance; Michael Schultz; Gareth J. Walker; Graham L. Radford-Smith; Susan J. Connor; Jane M. Andrews

doi:10.1016/S0016-5085(24)03074-9

Back

Mo1835 Dose Escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program

Conference paper

Peer reviewed

Mo1835 Dose Escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program

Basheer Alshiwanna, Jack McNamara, William E. Wilson, Joseph L. Pipicella, Simon Ghaly, Richard Gearry, Jakob Begun, Astrid-Jane Williams, Kate D. Lynch, Ian C. Lawrance, …

Gastroenterology (New York, N.Y. 1943), Vol.166(5), pp.S-1135-S-1135

18/05/2024

DOI: https://doi.org/10.1016/S0016-5085(24)03074-9

Handle:

https://hdl.handle.net/10523/40930

Metrics

10 Record Views

Details

Record Identifier: 9926556141701891
Title: Mo1835 Dose Escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program
Creators: Basheer Alshiwanna
Jack McNamara
William E. Wilson
Joseph L. Pipicella
Simon Ghaly
Richard Gearry
Jakob Begun
Astrid-Jane Williams
Kate D. Lynch
Ian C. Lawrance
Michael Schultz
Gareth J. Walker
Graham L. Radford-Smith
Susan J. Connor
Jane M. Andrews
Publication Details: Gastroenterology (New York, N.Y. 1943), Vol.166(5), pp.S-1135-S-1135
Academic Unit: Medicine (DSM); Medicine (UOC)
Date published ; e-published: 18/05/2024
Language: English
Resource Type ; Subtype: Conference paper; Conference Abstract

Mo1835 Dose Escalated Infliximab in Inflammatory Bowel Disease - Crohn's Colitis Cure (CCC) Data Insights Program

Related links

Metrics

Details